Fmoc-3-Fluoro-L-Phenylalanine

Fmoc-3-Fluoro-L-Phenylalanine is an Fmoc-protected L-phenylalanine derivative bearing a fluorine substituent at the 3-position of the aromatic ring, providing a chiral amino acid building block with a defined stereocenter at the alpha carbon. The molecule contains the Fmoc carbamate on the amino group and a carboxylic acid functionality suitable for peptide coupling after activation, while the aryl fluorine modulates electronics and enables targeted aromatic derivatization or fluorine-retaining structure design. The aromatic C-F bond and the fluorinated phenyl ring can influence conformational preferences, hydrophobicity, and hydrogen-bonding patterns in peptide and peptidomimetic contexts. As a protected amino acid intermediate, it is compatible with standard solid-phase and solution-phase peptide synthesis workflows that rely on orthogonal protection and predictable amide bond formation chemistry.

1. Peptide Synthesis

Fmoc-3-Fluoro-L-Phenylalanine is used in peptide building block preparation for solid-phase peptide synthesis and solution-phase coupling, where the Fmoc carbamate enables controlled N-terminal deprotection and subsequent amide bond formation. The combination of an Fmoc-protected amine and a carboxylic acid group supports activation with common coupling reagents to install the fluorinated phenylalanine residue at a defined position within a peptide chain. The 3-fluoro substitution provides a chemically stable aromatic handle that can be retained through peptide assembly to generate fluorinated analogs for binding studies, stability profiling, or conformational tuning. Downstream, the resulting fluorinated peptides can serve as reference standards, SAR probes, or mechanistic substrates in peptide science and chemical biology research.

2. Side-Chain Functionalization

Fmoc-3-Fluoro-L-Phenylalanine supports amino acid derivatization strategies that exploit the fluorinated aromatic side chain as a tunable physicochemical element rather than a reactive functional group. The aryl fluorine can be preserved during peptide construction to modulate lipophilicity and aromatic electronics, or it can potentially be transformed in later synthetic steps through fluorine-directed aromatic functionalization routes to access substituted phenyl motifs. The protected amino acid architecture allows orthogonal handling of the N-terminus during synthesis, while the fluorinated ring remains compatible with typical peptide purification conditions. Fluorinated side-chain incorporation can therefore feed into peptidomimetic construction, scaffold diversification, and downstream synthesis of labeled or electronically tuned aromatic derivatives.

3. Drug Discovery SAR Studies

Fmoc-3-Fluoro-L-Phenylalanine is applied in structure-activity relationship studies where fluorine substitution on a phenylalanine side chain helps probe binding-site interactions and metabolic stability trends for peptide-like ligands. The stereodefined L-configuration and the Fmoc-protected backbone facilitate incorporation into defined peptide sequences, enabling systematic comparison of analogs that differ primarily at the aromatic ring electronics. The presence of an aryl C-F bond allows retention of a discrete, non-hydrogen substituent that can influence conformational preferences and local dipole effects without introducing additional hydrogen-bond donors or acceptors. Resulting fluorinated peptide analogs can be used as chemical probes, reference ligands, and analytical materials to support SAR mapping and molecular design workflows.

4. Bioconjugation Chemistry

Fmoc-3-Fluoro-L-Phenylalanine can be incorporated into peptides or peptide fragments used for bioconjugation chemistry, where the fluorinated aromatic residue contributes to defined hydrophobic and electronic features that affect conjugate behavior. The Fmoc-protected amino acid format enables site-specific installation of the fluorinated phenylalanine within a peptide handle that can later be functionalized at other positions for coupling to biomolecules. The stable C-F bond can be beneficial for generating conjugates with consistent mass signatures and predictable chromatographic behavior, supporting downstream characterization and comparative studies across conjugate libraries. Fluorinated peptide conjugates prepared from this amino acid intermediate can serve as reagents for chemical biology experiments, biomolecule labeling workflows, and analytical method development.

5. Pharmaceutical Manufacturing

Fmoc-3-Fluoro-L-Phenylalanine is suitable for manufacturing-oriented synthesis of fluorinated peptide intermediates used in process chemistry and fine chemical production pipelines. The Fmoc protection strategy supports reproducible N-protection and deprotection steps, while the amino acid's defined stereochemistry helps maintain sequence integrity during scale-up of peptide coupling operations. The fluorinated aromatic ring can be retained through manufacturing steps to produce consistent, structurally characterized intermediates for further derivatization, formulation-relevant fragment generation, or reference material preparation. Industrially, the compound functions as a controlled chiral building block that aligns with established peptide synthesis infrastructure and supports downstream quality-by-design approaches for fluorinated amino acid-containing products.

6. Analytical Research Standards

Fmoc-3-Fluoro-L-Phenylalanine is utilized in analytical research for developing and validating methods involving fluorinated amino acid and peptide species. The presence of the Fmoc-protected amine and the fluorinated phenylalanine motif enables preparation of defined reference compounds and peptide standards that can be used to monitor derivatization, coupling efficiency, and identity confirmation in complex analytical workflows. The C-F bond provides a distinct spectroscopic and mass spectrometric signature that can facilitate targeted detection and structural verification of fluorinated residues in mixtures. As a result, this amino acid intermediate can support method development for LC-MS, NMR-based characterization, and comparative profiling of fluorinated peptide analogs in research and industrial quality control contexts.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

3. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

4. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

5. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction